ArticleJournal for immunotherapy of cancer2017

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.

Patrick M Dillon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.